JPWO2021047622A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021047622A5 JPWO2021047622A5 JP2022516434A JP2022516434A JPWO2021047622A5 JP WO2021047622 A5 JPWO2021047622 A5 JP WO2021047622A5 JP 2022516434 A JP2022516434 A JP 2022516434A JP 2022516434 A JP2022516434 A JP 2022516434A JP WO2021047622 A5 JPWO2021047622 A5 JP WO2021047622A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- cycloalkyl
- membered heterocycloalkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910863718 | 2019-09-12 | ||
| CN201910863718.6 | 2019-09-12 | ||
| CN201911094782.9 | 2019-11-11 | ||
| CN201911094782 | 2019-11-11 | ||
| CN202010531381 | 2020-06-11 | ||
| CN202010531381.1 | 2020-06-11 | ||
| CN202010923311.0 | 2020-09-04 | ||
| CN202010923311 | 2020-09-04 | ||
| PCT/CN2020/114700 WO2021047622A1 (zh) | 2019-09-12 | 2020-09-11 | 吡啶氮氧化合物及其制备方法和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022548104A JP2022548104A (ja) | 2022-11-16 |
| JPWO2021047622A5 true JPWO2021047622A5 (de) | 2023-09-27 |
Family
ID=74866555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516434A Pending JP2022548104A (ja) | 2019-09-12 | 2020-09-11 | ピリジン窒素酸化物及びその製造方法と使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230303495A9 (de) |
| EP (1) | EP4043437A4 (de) |
| JP (1) | JP2022548104A (de) |
| KR (1) | KR20220101606A (de) |
| CN (3) | CN118146148A (de) |
| AU (1) | AU2020346951A1 (de) |
| BR (1) | BR112022004495A8 (de) |
| CA (1) | CA3150400A1 (de) |
| CL (1) | CL2022000619A1 (de) |
| CO (1) | CO2022004594A2 (de) |
| MX (1) | MX2022003032A (de) |
| PE (1) | PE20221515A1 (de) |
| TW (1) | TWI770607B (de) |
| WO (1) | WO2021047622A1 (de) |
| ZA (1) | ZA202204100B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202300147A (zh) * | 2021-03-11 | 2023-01-01 | 大陸商上海濟煜醫藥科技有限公司 | 吡啶氮氧化合物晶型及其應用 |
| CN117794919A (zh) | 2021-06-04 | 2024-03-29 | 沃泰克斯药物股份有限公司 | N-(羟烷基(杂)芳基)四氢呋喃甲酰胺类似物作为钠通道调节剂 |
| CA3221960A1 (en) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channels |
| PE20241335A1 (es) | 2021-06-04 | 2024-07-03 | Vertex Pharma | N-(hidroxialquil (hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio |
| KR20240031299A (ko) | 2021-06-04 | 2024-03-07 | 버텍스 파마슈티칼스 인코포레이티드 | (2r,3s,4s,5r)-4-[[3-(3,4-디플루오로-2-메톡시-페닐)-4,5-디메틸-5-(트리플루오로메틸)테트라하이드로푸란-2-카르보닐]아미노]피리딘-2-카르복사미드를 포함하는 고체 투여 형태 및 투여 요법 |
| CA3221788A1 (en) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channels |
| CA3221938A1 (en) | 2021-06-04 | 2022-12-08 | Vertex Pharmaceuticals Incorporated | Substituted tetrahydrofuran analogs as modulators of sodium channels |
| IL313670A (en) | 2021-12-30 | 2024-08-01 | Biomea Fusion Inc | Pyrazine compounds as inhibitors of FLT3 |
| WO2023186102A1 (zh) * | 2022-04-02 | 2023-10-05 | 武汉人福创新药物研发中心有限公司 | Nav1.8抑制剂及其用途 |
| WO2023205468A1 (en) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| WO2023205465A1 (en) | 2022-04-22 | 2023-10-26 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| US20230382910A1 (en) | 2022-04-22 | 2023-11-30 | Vertex Pharmaceuticals Incorporated | Heteroaryl compounds for the treatment of pain |
| TW202404969A (zh) | 2022-04-22 | 2024-02-01 | 美商維泰克斯製藥公司 | 用於治療疼痛之雜芳基化合物 |
| TW202348229A (zh) * | 2022-06-02 | 2023-12-16 | 大陸商上海濟煜醫藥科技有限公司 | 吡啶氮氧化合物的製備方法 |
| TW202413335A (zh) * | 2022-06-22 | 2024-04-01 | 大陸商武漢人福創新藥物研發中心有限公司 | Ｎａｖ１．８抑制劑 |
| WO2024123815A1 (en) | 2022-12-06 | 2024-06-13 | Vertex Pharmaceuticals Incorporated | Process for the synthesis of substituted tetrahydrofuran modulators of sodium channels |
| WO2024153856A1 (en) | 2023-01-18 | 2024-07-25 | Orion Corporation | Process for the preparation of 3-(4,5-dichloro-2-(4-(trifluoromethoxy)phenoxy)benzamido)pyridine 1-oxide |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834468A (en) * | 1995-07-07 | 1998-11-10 | Zeneca Limited | Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| US8067638B2 (en) * | 2005-06-21 | 2011-11-29 | Mitsui Chemicals, Inc. | Amide derivative and insecticide containing the same |
| MX2008013194A (es) * | 2006-04-11 | 2008-12-01 | Vertex Pharma | Composiciones utiles como inhibidores de canales de sodio regulados por voltaje. |
| JP2010047480A (ja) * | 2006-12-19 | 2010-03-04 | Mitsui Chemicals Inc | 虫害の予防方法 |
| US8389734B2 (en) * | 2007-10-11 | 2013-03-05 | Vertex Pharmaceuticals Incorporated | Amides useful as inhibitors of voltage-gated sodium channels |
| CA2702101A1 (en) * | 2007-10-11 | 2009-04-16 | Vertex Pharmaceuticals Incorporated | Aryl amides useful as inhibitors of voltage-gated sodium channels |
| KR20130119964A (ko) * | 2010-12-22 | 2013-11-01 | 퍼듀 퍼머 엘피 | 나트륨 채널 차단제로서의 치환된 피리딘 |
| ES2620379T3 (es) * | 2013-01-31 | 2017-06-28 | Vertex Pharmaceuticals Inc. | Quinolina y quinoxalina amidas como moduladores de canales de sodio |
| UY35288A (es) * | 2013-01-31 | 2014-08-29 | Vertex Pharma | Piridonamidas como moduladores de canales de sodio |
| SG11201505954RA (en) * | 2013-01-31 | 2015-08-28 | Vertex Pharma | Amides as modulators of sodium channels |
| SG11201604477SA (en) * | 2013-12-13 | 2016-07-28 | Vertex Pharma | Prodrugs of pyridone amides useful as modulators of sodium channels |
| JOP20200001A1 (ar) * | 2017-07-11 | 2022-10-30 | Vertex Pharma | كاربوكسأميدات بوصفها معدلات لقنوات الصوديوم |
| EP3820866A4 (de) * | 2018-07-09 | 2022-04-06 | Lieber Institute, Inc. | Pyridincarboxamidverbindungen zur hemmung von nav1.8 |
-
2020
- 2020-09-11 CN CN202410255352.5A patent/CN118146148A/zh active Pending
- 2020-09-11 CA CA3150400A patent/CA3150400A1/en active Pending
- 2020-09-11 JP JP2022516434A patent/JP2022548104A/ja active Pending
- 2020-09-11 KR KR1020227012157A patent/KR20220101606A/ko unknown
- 2020-09-11 MX MX2022003032A patent/MX2022003032A/es unknown
- 2020-09-11 TW TW109131318A patent/TWI770607B/zh active
- 2020-09-11 BR BR112022004495A patent/BR112022004495A8/pt unknown
- 2020-09-11 WO PCT/CN2020/114700 patent/WO2021047622A1/zh unknown
- 2020-09-11 US US17/642,020 patent/US20230303495A9/en active Pending
- 2020-09-11 PE PE2022000407A patent/PE20221515A1/es unknown
- 2020-09-11 AU AU2020346951A patent/AU2020346951A1/en active Pending
- 2020-09-11 EP EP20863934.4A patent/EP4043437A4/de active Pending
- 2020-09-11 CN CN202080037787.2A patent/CN113906013B/zh active Active
- 2020-09-11 CN CN202010957957.0A patent/CN112479996B/zh active Active
-
2022
- 2022-03-11 CL CL2022000619A patent/CL2022000619A1/es unknown
- 2022-04-11 CO CONC2022/0004594A patent/CO2022004594A2/es unknown
- 2022-04-11 ZA ZA2022/04100A patent/ZA202204100B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112479996B (zh) | 吡啶氮氧化合物及其制备方法和用途 | |
| CN112225695B (zh) | 一种氮氧化合物及其制备方法和用途 | |
| CN112457294B (zh) | 一种作为NaV1.8阻滞剂的化合物及其制备方法和用途 | |
| CN111808019B (zh) | 一种并环化合物及其应用 | |
| JPWO2021047622A5 (de) | ||
| US10604502B2 (en) | Substituted 5-cyanoindole compounds and uses thereof | |
| BR112016008133B1 (pt) | amino-heteroaril benzamidas como inibidores de quinase, seus usos, e composição farmacêutica | |
| EP3891157A1 (de) | 4-amino- oder 4-alkoxysubstituierte arylsulfonamidverbindungen mit selektiver aktivität in spannungsgesteuerten natriumkanälen | |
| AU2013326486A1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
| EP4334293A1 (de) | Cycloalkyl-3-oxopiperazincarboxamide und cycloheteroalkyl-3-oxopiperazincarboxamide als nav1.8-inhibitoren | |
| JP2021527660A (ja) | ＲＯＲγｔのモジュレータとしてのフェニル及びピリジニル置換イミダゾール | |
| JP2023513373A (ja) | Ｐ２ｘ３修飾薬 | |
| JP2023522863A (ja) | Ｅｇｆｒ阻害剤としての三環式化合物 | |
| KR20220106778A (ko) | 간 x 수용체 작용제로서의 1,2,4-옥사디아졸 유도체 | |
| TW202304864A (zh) | 1,3-取代的環丁基衍生物及其用途 | |
| EP3724196B1 (de) | Substituierte azetidindihydrothienopyrimidine und ihre verwendung als phosphodiesterase-inhibitoren | |
| JP2013514327A (ja) | ｍＧｌｕＲ５受容体のアロステリック調節因子としての二環式チアゾール | |
| TW202408503A (zh) | 治療纖維化之方法 | |
| WO2023011608A1 (zh) | 含三并环类衍生物调节剂、其制备方法和应用 | |
| TW202237577A (zh) | 化合物、組合物及方法 | |
| CN113015735A (zh) | 用于诱导软骨发生以治疗关节损害的5-羟基-7-氧杂双环[2.2.1]庚烷-2-甲酰胺衍生物 | |
| WO2024099404A1 (zh) | 一种含氮螺环类化合物、药物组合物以及其用途 | |
| WO2023154291A1 (en) | Modulators of cystic fibrosis transmembrane conductance regulator | |
| WO2024099403A1 (zh) | 一种具有软药性质的硫醚类化合物、药物组合物及其用途 | |
| JP2024038267A (ja) | Ｎａｖ１．８阻害薬としてのシクロアルキル ３－オキソピペラジンカルボキサミド類及びシクロヘテロアルキル ３－オキソピペラジンカルボキサミド類 |